Signal Transduction and Targeted Therapy

期刊名
Signal Transduction and Targeted Therapy

SIGNAL TRANSDUCT TAR

ISSN / eISSN
2095-9907 / 2059-3635
目标和范围
Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.
研究方向

生化与分子生物学

细胞生物学

CiteScore
44.50 查看趋势图
CiteScore 学科排名
类别 分区 排名
Biochemistry, Genetics and Molecular Biology - Genetics Q1 #2/347
Biochemistry, Genetics and Molecular Biology - Cancer Research Q1 #5/230
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2024) 分区
BIOCHEMISTRY & MOLECULAR BIOLOGY Q1
CELL BIOLOGY Q1
出版国家或地区
United Kingdom
出版商
Springer Nature
出版年份
2016
年文章数
272
Open Access
YES
通讯方式
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
Although the impact factor is increasing rapidly, most of the impact factors are achieved through letter publications, and it is easier to be accepted by submitting in letter format. However, it is important to remind everyone that a small number of institutions have regulations that letters (excluding Nature's letters) are not considered articles and cannot be used for promotion or awards. Considering this trend, the publication volume of letters in domestic journals is very high, leading to internal competition, and only raising assessment standards. I believe that this trend will continue to spread in the future. Those who want to go far in scientific research should carefully consider submitting letters, including letters from Cell Research, as they may no longer be considered articles in the future.
2021-03-26
I don't understand why there are so many sour grape mentality people who can't stand to see domestic journals improve. Is mindlessly criticizing interesting? If you have the ability, publish an article there and then speak. Anyway, if our papers are not accepted by top-tier journals or major journals, we will consider submitting them here, but it is also difficult to get accepted. Many papers that were rejected by STTT were accepted by NC, and there are quite a few accepted by Cell Reports. At the very least, this proves that STTT has a higher difficulty level for manuscript submission compared to regular journals.
2023-08-09

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started